Newsroom

News Release from HHS.gov: HHS commits up to $300 million over 10 years to combat antibiotic-resistant bacteria

WEB ANNOUNCEMENTS

May 19, 2022

News Release from HHS.gov: HHS commits up to $300 million over 10 years to combat antibiotic-resistant bacteria

BARDA announces new partnerships to develop next-gen diagnostics for any respiratory RNA virus

WEB ANNOUNCEMENTS

May 03, 2022

BARDA announces new partnerships to develop next-gen diagnostics for any respiratory RNA virus

We're proud of our 2022 SAMMIES Finalists

WEB ANNOUNCEMENTS

May 02, 2022

We're proud of our 2022 SAMMIES Finalists

BARDA and Lumen Bioscience partner on a rapidly scalable novel manufacturing platform to develop an intranasal antibody cocktail to treat COVID-19

WEB ANNOUNCEMENTS

April 27, 2022

BARDA and Lumen Bioscience partner on a rapidly scalable novel manufacturing platform to develop an intranasal antibody cocktail to treat COVID-19

Unlocking Insights from Real-World Data to Help Pediatric COVID-19 Patients

BLOGS/STORIES

April 06, 2022

Unlocking Insights from Real-World Data to Help Pediatric COVID-19 Patients

2022 NEXT-GEN FILOVIRUS THERAPEUTICS WORKSHOP - March 9, 2022

EVENTS/MEETINGS

March 09, 2022

2022 NEXT-GEN FILOVIRUS THERAPEUTICS WORKSHOP - March 9, 2022

BARDA continues long-standing partnerships with GSK, Sanofi, and Seqirus to strengthen preparedness and rapid response capabilities for influenza pandemics

WEB ANNOUNCEMENTS

February 25, 2022

BARDA continues long-standing partnerships with GSK, Sanofi, and Seqirus to strengthen preparedness and rapid response capabilities for influenza pandemics

HHS News Release: Secretary Becerra Announces HHS Purchase of 600,000 Treatment Courses of New Monoclonal Antibody That Works Against Omicron

WEB ANNOUNCEMENTS

February 15, 2022

HHS News Release: Secretary Becerra Announces HHS Purchase of 600,000 Treatment Courses of New Monoclonal Antibody That Works Against Omicron

BARDA partners with Detect, Inc. to develop a rapid molecular diagnostic test for over-the-counter use to indentify SARS-CoV-2 and influenza A and B infection

WEB ANNOUNCEMENTS

February 03, 2022

BARDA partners with Detect, Inc. to develop a rapid molecular diagnostic test for over-the-counter use to indentify SARS-CoV-2 and influenza A and B infection

BLOGS/STORIES

February 01, 2022

BARDA’s First 15 Years

EVENTS/MEETINGS

January 26, 2022

2022 Filovirus Vaccine Development Workshop - January 26, 2022

BARDA seeks proposals for late-stage antibiotic development to mitigate the threat of antibiotic resistant infections

WEB ANNOUNCEMENTS

January 21, 2022

BARDA seeks proposals for late-stage antibiotic development to mitigate the threat of antibiotic resistant infections

EVENTS/MEETINGS

January 20, 2022

BioPharmaceutical Manufacturing Partnership Consortium (BIOMAC) Industry Day - January 20, 2022

BARDA and HHS to host National Biopharmaceutical Manufacturing Consortium (BioMaC) Industry Day

WEB ANNOUNCEMENTS

January 12, 2022

BARDA and HHS to host National Biopharmaceutical Manufacturing Consortium (BioMaC) Industry Day

The Mask Innovation Challenge Goes From Paper to Prototype

BLOGS/STORIES

December 21, 2021

The Mask Innovation Challenge Goes From Paper to Prototype

BARDA seeks partners to develop host-directed therapeutic solutions to improve long-term recovery from acute respiratory distress

WEB ANNOUNCEMENTS

December 17, 2021

BARDA seeks partners to develop host-directed therapeutic solutions to improve long-term recovery from acute respiratory distress

BARDA launches Phase 2 of $500,000 contest for prototypes of new, effective, comfortable masks for general public use

WEB ANNOUNCEMENTS

December 06, 2021

BARDA launches Phase 2 of $500,000 contest for prototypes of new, effective, comfortable masks for general public use

BARDA seeks abstract submissions for medical countermeasure development through the DRIVe ReDIRECT Program

WEB ANNOUNCEMENTS

December 03, 2021

BARDA seeks abstract submissions for medical countermeasure development through the DRIVe ReDIRECT Program

BLOGS/STORIES

November 23, 2021

Combatting Antimicrobial Resistance

Partnering to Protect: Public & Private Sectors Unite Against Antimicrobial Resistance

BLOGS/STORIES

November 19, 2021

Partnering to Protect: Public & Private Sectors Unite Against Antimicrobial Resistance

HHS News Release: Biden Administration Secures 10 Million Courses of Pfizer’s COVID-19 Oral Antiviral Medicine as Additional Tool to Reduce Hospitalizations and Save Lives

WEB ANNOUNCEMENTS

November 18, 2021

HHS News Release: Biden Administration Secures 10 Million Courses of Pfizer’s COVID-19 Oral Antiviral Medicine as Additional Tool to Reduce Hospitalizations and Save Lives

EVENTS/MEETINGS

November 03, 2021

BARDA Industry Day - November 3-4, 2021

VIDEOS

November 03, 2021

BARDA Industry Day 2021 Presentation Videos

$BARDA partners with RIVANNA to develop an ultrasound based, radiation free, rapid fracture detection device$

WEB ANNOUNCEMENTS

October 29, 2021

BARDA partners with RIVANNA to develop an ultrasound based, radiation free, rapid fracture detection device

BARDA and BD collaborate on diagnostic testing to address COVID-19, influenza, and novel and emerging coronaviruses

WEB ANNOUNCEMENTS

October 28, 2021

BARDA and BD collaborate on diagnostic testing to address COVID-19, influenza, and novel and emerging coronaviruses

Disaster Medicine: Sepsis training module developed through a BARDA and Sepsis Alliance partnership to address sepsis encountered in austere conditions following disasters

WEB ANNOUNCEMENTS

October 21, 2021

Disaster Medicine: Sepsis training module developed through a BARDA and Sepsis Alliance partnership to address sepsis encountered in austere conditions following disasters

BARDA seeks applications for developing at-home COVID-19 diagnostics and technologies

WEB ANNOUNCEMENTS

October 20, 2021

BARDA seeks applications for developing at-home COVID-19 diagnostics and technologies

BLOGS/STORIES

October 08, 2021

2021 Federal Wearables Summit

BARDA and Vedanta Biosciences partner for Phase 3 clinical trial of VE303 as a potential treatment for C. difficile bacterial infections

WEB ANNOUNCEMENTS

October 05, 2021

BARDA and Vedanta Biosciences partner for Phase 3 clinical trial of VE303 as a potential treatment for C. difficile bacterial infections

BARDA and Clarivate collaborate on using advanced computational approaches to identify therapeutics that can be repurposed to treat chlorine or sulfur mustard injuries

WEB ANNOUNCEMENTS

September 28, 2021

BARDA and Clarivate collaborate on using advanced computational approaches to identify therapeutics that can be repurposed to treat chlorine or sulfur mustard injuries

BARDA partners with Aidar Health, Inc. to develop and validate machine learning algorithm for rapid health assessment and patient triage

WEB ANNOUNCEMENTS

September 27, 2021

BARDA partners with Aidar Health, Inc. to develop and validate machine learning algorithm for rapid health assessment and patient triage

BARDA renews collaboration with OraSure Technologies, Inc. on InteliSwab COVID-19 Rapid Test

WEB ANNOUNCEMENTS

September 23, 2021

BARDA renews collaboration with OraSure Technologies, Inc. on InteliSwab COVID-19 Rapid Test

BARDA and NCATS announce three new EZ-BAA partners for the ImmuneChip+ program to advance tissue-chip technology for immunity, vaccine, and drug development studies

WEB ANNOUNCEMENTS

September 23, 2021

BARDA and NCATS announce three new EZ-BAA partners for the ImmuneChip+ program to advance tissue-chip technology for immunity, vaccine, and drug development studies

BARDA and Partner Therapeutics collaborate on development of a novel assay to stratify sepsis patients that may benefit from an immune therapeutic

WEB ANNOUNCEMENTS

September 20, 2021

BARDA and Partner Therapeutics collaborate on development of a novel assay to stratify sepsis patients that may benefit from an immune therapeutic

BARDA Continues Transatlantic Collaboration to Address the Urgent Threat of Antimicrobial Resistance

WEB ANNOUNCEMENTS

September 14, 2021

BARDA Continues Transatlantic Collaboration to Address the Urgent Threat of Antimicrobial Resistance

BARDA and Sentien Biotechnologies partner on a novel ex vivo cell-based therapy to reduce disease severity in sepsis patients

WEB ANNOUNCEMENTS

September 02, 2021

BARDA and Sentien Biotechnologies partner on a novel ex vivo cell-based therapy to reduce disease severity in sepsis patients

VIDEOS

August 31, 2021

BARDA DRIVe 2021 Federal Wearables Summit: Dr. Gary Disbrow Welcome Remarks

BARDA DRIVe evolves its ENACT program into two areas of disruptive technology development of purely digital health tools and at-home diagnostic testing

WEB ANNOUNCEMENTS

August 30, 2021

BARDA DRIVe evolves its ENACT program into two areas of disruptive technology development of purely digital health tools and at-home diagnostic testing

BARDA seeks partners to develop agnostic diagnostic assays

WEB ANNOUNCEMENTS

August 24, 2021

BARDA seeks partners to develop agnostic diagnostic assays

BARDA continues partnership with Velico Medical for development of their FrontlineODP spray-dry plasma system to prepare for a radiological or nuclear emergency

WEB ANNOUNCEMENTS

August 23, 2021

BARDA continues partnership with Velico Medical for development of their FrontlineODP spray-dry plasma system to prepare for a radiological or nuclear emergency

Calling all computational model developers! Big-data competition opens to help children at risk for severe COVID-19

WEB ANNOUNCEMENTS

August 20, 2021

Calling all computational model developers! Big-data competition opens to help children at risk for severe COVID-19

Clinical trial results suggest BARDA-supported long-acting antibody combination can prevent COVID-19

WEB ANNOUNCEMENTS

August 20, 2021

Clinical trial results suggest BARDA-supported long-acting antibody combination can prevent COVID-19

BARDA and Venatorx Pharmaceuticals partner to evaluate drug in Phase 3 clinical trial as potential treatment for drug-resistant and nosocomial bacterial infections

WEB ANNOUNCEMENTS

August 16, 2021

BARDA and Venatorx Pharmaceuticals partner to evaluate drug in Phase 3 clinical trial as potential treatment for drug-resistant and nosocomial bacterial infections

BLOGS/STORIES

August 10, 2021

Correlates of Protection

BARDA DRIVe partners with US Biologic Inc. in the development of an oral vaccine for pandemic influenza

WEB ANNOUNCEMENTS

August 05, 2021

BARDA DRIVe partners with US Biologic Inc. in the development of an oral vaccine for pandemic influenza

BARDA and Cepheid collaborate on rapid diagnostic testing for pooled samples to address COVID-19, detect novel and emerging coronaviruses, and increase pandemic preparedness

WEB ANNOUNCEMENTS

July 27, 2021

BARDA and Cepheid collaborate on rapid diagnostic testing for pooled samples to address COVID-19, detect novel and emerging coronaviruses, and increase pandemic preparedness

Learn about BARDA Regulatory & Quality Affairs' role in the COVID-19 response and the differences between a COVID-19 EUA and a traditional FDA approval

BLOGS/STORIES

July 21, 2021

Learn about BARDA Regulatory & Quality Affairs' role in the COVID-19 response and the differences between a COVID-19 EUA and a traditional FDA approval

News release from Defense.gov: DOD Awards $35.1 Million Contract to LightDeck Diagnostics to Increase Production Capacity of COVID-19 Point-of-Care Tests

WEB ANNOUNCEMENTS

July 08, 2021

News release from Defense.gov: DOD Awards $35.1 Million Contract to LightDeck Diagnostics to Increase Production Capacity of COVID-19 Point-of-Care Tests

Now Accepting Applications for BARDA Industry Day 2021 Lightning Talks

WEB ANNOUNCEMENTS

July 07, 2021

Now Accepting Applications for BARDA Industry Day 2021 Lightning Talks

BARDA-NIOSH Mask Innovation Challenge Selects 10 Winning Concepts for $10,000 Phase 1 Prizes

BLOGS/STORIES

July 02, 2021

BARDA-NIOSH Mask Innovation Challenge Selects 10 Winning Concepts for $10,000 Phase 1 Prizes

New antibiotic purchased under Project BioShield to treat anthrax infections

WEB ANNOUNCEMENTS

July 01, 2021

New antibiotic purchased under Project BioShield to treat anthrax infections

BARDA and BioAegis Therapeutics partner on a novel human protein therapy to reduce disease severity in patients with severe infection and sepsis

WEB ANNOUNCEMENTS

June 28, 2021

BARDA and BioAegis Therapeutics partner on a novel human protein therapy to reduce disease severity in patients with severe infection and sepsis

BARDA Industry Day 2021 Lightning Talks - Registration Coming Soon

WEB ANNOUNCEMENTS

June 25, 2021

BARDA Industry Day 2021 Lightning Talks - Registration Coming Soon

News Release from HHS.gov: Biden Administration to Invest $3 Billion from American Rescue Plan as Part of COVID-19 Antiviral Development Strategy

WEB ANNOUNCEMENTS

June 22, 2021

News Release from HHS.gov: Biden Administration to Invest $3 Billion from American Rescue Plan as Part of COVID-19 Antiviral Development Strategy

Global collaboration with BARDA scientists successfully develop Ebola countermeasures

BLOGS/STORIES

June 21, 2021

Global collaboration with BARDA scientists successfully develop Ebola countermeasures

BARDA announces the 61st FDA Approval/Licensure/Clearance for Medical Countermeasures supported by BARDA under Novel Public Private Partnerships

WEB ANNOUNCEMENTS

June 16, 2021

BARDA announces the 61st FDA Approval/Licensure/Clearance for Medical Countermeasures supported by BARDA under Novel Public Private Partnerships

BARDA and Moderna TX expand COVID-19 vaccine clinical trials with pediatric population

WEB ANNOUNCEMENTS

June 16, 2021

BARDA and Moderna TX expand COVID-19 vaccine clinical trials with pediatric population

Updated Instructions: Seeking Proposals: Antibacterial Accelerator Broad Agency Announcement Special Instructions

WEB ANNOUNCEMENTS

June 14, 2021

Updated Instructions: Seeking Proposals: Antibacterial Accelerator Broad Agency Announcement Special Instructions

News release from HHS.gov: Biden Administration announces U.S. government procurement of Merck’s investigational antiviral medicine for COVID-19 treatment

WEB ANNOUNCEMENTS

June 09, 2021

News release from HHS.gov: Biden Administration announces U.S. government procurement of Merck’s investigational antiviral medicine for COVID-19 treatment

BARDA and Dascena, Inc. partner to further advance machine learning software to predict early health deterioration in hospitalized COVID-19 patients

WEB ANNOUNCEMENTS

June 09, 2021

BARDA and Dascena, Inc. partner to further advance machine learning software to predict early health deterioration in hospitalized COVID-19 patients

News release from Defense.gov: DOD, HHS Award $4.6 Million Contract to DiaSorin Inc. to Increase Production of COVID-19 Tests

WEB ANNOUNCEMENTS

June 08, 2021

News release from Defense.gov: DOD, HHS Award $4.6 Million Contract to DiaSorin Inc. to Increase Production of COVID-19 Tests

BARDA’s Antimicrobial Resistance (AMR) Program Looks to the Future

BLOGS/STORIES

June 08, 2021

BARDA’s Antimicrobial Resistance (AMR) Program Looks to the Future

BARDA announces its 60th FDA Approval/Licensure/Clearance for Medical Countermeasures supported by BARDA under Novel Public Private Partnerships

WEB ANNOUNCEMENTS

June 07, 2021

BARDA announces its 60th FDA Approval/Licensure/Clearance for Medical Countermeasures supported by BARDA under Novel Public Private Partnerships

News release from HHS.gov: HHS launches first venture capital partnership to develop transformative technologies to combat future pandemics, other health emergencies

WEB ANNOUNCEMENTS

June 01, 2021

News release from HHS.gov: HHS launches first venture capital partnership to develop transformative technologies to combat future pandemics, other health emergencies

BARDA Industry Day 2021 Save the Date: November 3-4, 2021 - Virtual Event

WEB ANNOUNCEMENTS

May 14, 2021

BARDA Industry Day 2021 Save the Date: November 3-4, 2021 - Virtual Event

BARDA and AgileMD partner to deploy electronic health record integrated software tool for rapid and early identification of COVID-19 patients in need of emergency interventions

WEB ANNOUNCEMENTS

May 05, 2021

BARDA and AgileMD partner to deploy electronic health record integrated software tool for rapid and early identification of COVID-19 patients in need of emergency interventions

BARDA and PeraHealth partner to develop machine learning app to aid in assessments and triage of COVID-19 patients in the Emergency Department

WEB ANNOUNCEMENTS

May 05, 2021

BARDA and PeraHealth partner to develop machine learning app to aid in assessments and triage of COVID-19 patients in the Emergency Department

VIDEOS

May 04, 2021

BARDA Vaccine Market Research Workshop

Message from the Director: 3 BARDA scientists recognized for their contributions to Ebola control

WEB ANNOUNCEMENTS

May 03, 2021

Message from the Director: 3 BARDA scientists recognized for their contributions to Ebola control

BARDA and Enalare Therapeutics announce partnership to advance ENA-001 as an emergency treatment for opioid-induced respiratory depression in the community setting

WEB ANNOUNCEMENTS

April 23, 2021

BARDA and Enalare Therapeutics announce partnership to advance ENA-001 as an emergency treatment for opioid-induced respiratory depression in the community setting

Innovation challenge seeks to solve a common hurdle in curbing coronavirus spread: mask design

BLOGS/STORIES

April 08, 2021

Innovation challenge seeks to solve a common hurdle in curbing coronavirus spread: mask design

BARDA and the Janssen Pharmaceutical Companies of Johnson & Johnson expand Phase 2a COVID-19 vaccine trial to include adolescent population

WEB ANNOUNCEMENTS

April 02, 2021

BARDA and the Janssen Pharmaceutical Companies of Johnson & Johnson expand Phase 2a COVID-19 vaccine trial to include adolescent population

BARDA and Department of the Air Force’s Acquisition COVID-19 Task Force (DAF ACT) Awards $53.7 Million Contract to Ortho Clinical Diagnostics

WEB ANNOUNCEMENTS

April 01, 2021

BARDA and Department of the Air Force’s Acquisition COVID-19 Task Force (DAF ACT) Awards $53.7 Million Contract to Ortho Clinical Diagnostics

News Release from PHE.gov: HHS launches $500,000 contest for design of new, effective, comfortable, masks designed for general public use

WEB ANNOUNCEMENTS

March 31, 2021

News Release from PHE.gov: HHS launches $500,000 contest for design of new, effective, comfortable, masks designed for general public use

BARDA and FirstString Research announce partnership to repurpose aCT1 eye drops as a medical countermeasure against mustard gas keratopathy

WEB ANNOUNCEMENTS

March 30, 2021

BARDA and FirstString Research announce partnership to repurpose aCT1 eye drops as a medical countermeasure against mustard gas keratopathy

BARDA expands partnership with DiaSorin SpA to develop automated antigen detection assay for acute COVID-19

WEB ANNOUNCEMENTS

March 29, 2021

BARDA expands partnership with DiaSorin SpA to develop automated antigen detection assay for acute COVID-19

BARDA partners with NCATS to seek submissions for the development of advanced microphysiological immune tissue platforms through its new DRIVe ImmuneChip+ program

WEB ANNOUNCEMENTS

March 15, 2021

BARDA partners with NCATS to seek submissions for the development of advanced microphysiological immune tissue platforms through its new DRIVe ImmuneChip+ program

BARDA Vaccines Against AMR Threats Workshop

EVENTS/MEETINGS

March 12, 2021

BARDA Vaccines Against AMR Threats Workshop

BARDA and ContraFect partner to develop an antibacterial to treat Staphylococcus aureus bacteremia

WEB ANNOUNCEMENTS

March 12, 2021

BARDA and ContraFect partner to develop an antibacterial to treat Staphylococcus aureus bacteremia

BARDA and MediciNova, Inc. partner to repurpose MN-166 (ibudilast) as a medical countermeasure against chlorine exposure

WEB ANNOUNCEMENTS

March 09, 2021

BARDA and MediciNova, Inc. partner to repurpose MN-166 (ibudilast) as a medical countermeasure against chlorine exposure

News Release from HHS.gov: Biden Administration Announces Historic Manufacturing Collaboration Between Merck and Johnson & Johnson to Expand Production of COVID-19 Vaccines

WEB ANNOUNCEMENTS

March 03, 2021

News Release from HHS.gov: Biden Administration Announces Historic Manufacturing Collaboration Between Merck and Johnson & Johnson to Expand Production of COVID-19 Vaccines

BARDA expands partnership with Hologic for development of a fourth high-throughput molecular assay for SARS-CoV-2

WEB ANNOUNCEMENTS

March 02, 2021

BARDA expands partnership with Hologic for development of a fourth high-throughput molecular assay for SARS-CoV-2

NEWS RELEASE FROM PHE.GOV: Biden Administration secures supply of new COVID-19 therapeutic treatment

WEB ANNOUNCEMENTS

March 02, 2021

NEWS RELEASE FROM PHE.GOV: Biden Administration secures supply of new COVID-19 therapeutic treatment

BARDA partners with LightDeck Diagnostics to develop a rapid, in vitro, point-of-care SARS-CoV-2 antigen test to detect SARS-CoV-2 infection

WEB ANNOUNCEMENTS

March 01, 2021

BARDA partners with LightDeck Diagnostics to develop a rapid, in vitro, point-of-care SARS-CoV-2 antigen test to detect SARS-CoV-2 infection

VIDEOS

March 01, 2021

Statement: BARDA director on emergency use authorization of the third COVID-19 vaccine

News Release from NIH.gov: Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Janssen COVID-19 Vaccine

WEB ANNOUNCEMENTS

February 27, 2021

News Release from NIH.gov: Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Janssen COVID-19 Vaccine

VIDEOS

February 25, 2021

#ASKBARDA - What does it mean when a clinical trial is paused?

VIDEOS

February 25, 2021

#ASKBARDA - Can you walk us through how clinical trial protocols have safety measures built in?

VIDEOS

February 25, 2021

#ASKBARDA - When a clinical trial is paused, or stopped, is that planned?

VIDEOS

February 25, 2021

#ASKBARDA - Why can't we know if the trial participant received the actual product or the placebo?

VIDEOS

February 25, 2021

#ASKBARDA - What is an independent Data Safety Monitoring Board (DSMB)?

VIDEOS

February 25, 2021

#ASKBARDA - What are some possible outcomes after the Data Safety Monitoring Board meets?

BARDA and Luminex Corporation collaborate on a single, rapid diagnostic test to distinguish coronavirus from influenza and RSV infections

WEB ANNOUNCEMENTS

February 19, 2021

BARDA and Luminex Corporation collaborate on a single, rapid diagnostic test to distinguish coronavirus from influenza and RSV infections

NEWS RELEASE FROM HHS.GOV: Biden Administration purchases additional doses of COVID-19 vaccines from Pfizer and Moderna

WEB ANNOUNCEMENTS

February 11, 2021

NEWS RELEASE FROM HHS.GOV: Biden Administration purchases additional doses of COVID-19 vaccines from Pfizer and Moderna

VIDEOS

February 09, 2021

BARDA COVID-19 Response: Dr. Robert Johnson, BARDA IEIDD Division Director and BARDA COVID-19 Response Lead

BARDA and Visby Medical partner to develop a rapid, hand-held, point-of-care and over-the-counter in vitro diagnostic test for influenza A/B and SARS-CoV-2.

WEB ANNOUNCEMENTS

February 02, 2021

BARDA and Visby Medical partner to develop a rapid, hand-held, point-of-care and over-the-counter in vitro diagnostic test for influenza A/B and SARS-CoV-2.

VIDEOS

January 21, 2021

BARDA DRIVe Program

BARDA, DOD, increase number of Lilly’s COVID-19 therapeutic treatment courses that can be purchased under agreement

WEB ANNOUNCEMENTS

January 13, 2021

BARDA, DOD, increase number of Lilly’s COVID-19 therapeutic treatment courses that can be purchased under agreement

BARDA and DiaSorin Molecular LLC collaborate on SARS-CoV-2 diagnostic test to distinguish coronavirus from influenza infections

WEB ANNOUNCEMENTS

January 13, 2021

BARDA and DiaSorin Molecular LLC collaborate on SARS-CoV-2 diagnostic test to distinguish coronavirus from influenza infections

NEWS RELEASE FROM PHE.GOV: HHS, DOD purchase additional doses of Regeneron’s antibody therapeutic to treat patients with mild to moderate COVID-19

WEB ANNOUNCEMENTS

January 12, 2021

NEWS RELEASE FROM PHE.GOV: HHS, DOD purchase additional doses of Regeneron’s antibody therapeutic to treat patients with mild to moderate COVID-19

BARDA DRIVe and NIOSH seek expert input on criteria for upcoming mask innovation challenge

WEB ANNOUNCEMENTS

January 07, 2021

BARDA DRIVe and NIOSH seek expert input on criteria for upcoming mask innovation challenge

Message from the BARDA Director: Thanks for supporting BARDA in 2020

WEB ANNOUNCEMENTS

December 30, 2020

Message from the BARDA Director: Thanks for supporting BARDA in 2020

News release from HHS.Gov: HHS, DOD collaborate with Merck to continue the development and large-scale manufacturing of investigational COVID-19 treatment

WEB ANNOUNCEMENTS

December 23, 2020

News release from HHS.Gov: HHS, DOD collaborate with Merck to continue the development and large-scale manufacturing of investigational COVID-19 treatment

News Release from HHS.gov: Trump Administration purchases additional 100 million doses of COVID-19 investigational vaccine from Pfizer

WEB ANNOUNCEMENTS

December 23, 2020

News Release from HHS.gov: Trump Administration purchases additional 100 million doses of COVID-19 investigational vaccine from Pfizer

BARDA announces the 57th FDA Approval/Licensure/Clearance for Medical Countermeasures supported by BARDA under Novel Public Private Partnerships

WEB ANNOUNCEMENTS

December 21, 2020

BARDA announces the 57th FDA Approval/Licensure/Clearance for Medical Countermeasures supported by BARDA under Novel Public Private Partnerships

News Release from NIH.gov: Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine

WEB ANNOUNCEMENTS

December 18, 2020

News Release from NIH.gov: Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine

NEWS RELEASE FROM HHS.GOV: HHS, DOD engage Quantum Leap Healthcare Collaborative in search for effective treatments for the sickest COVID-19 patients

WEB ANNOUNCEMENTS

December 15, 2020

NEWS RELEASE FROM HHS.GOV: HHS, DOD engage Quantum Leap Healthcare Collaborative in search for effective treatments for the sickest COVID-19 patients

News Release from HHS.GOV: Trump Administration purchases additional 100 million doses of COVID-19 investigational vaccine from Moderna

WEB ANNOUNCEMENTS

December 11, 2020

News Release from HHS.GOV: Trump Administration purchases additional 100 million doses of COVID-19 investigational vaccine from Moderna

The Global Health Technologies Coalition 2020 Innovating for Impact Partnership award recognizes CARB-X for its work to transform breakthrough scientific research into lifesaving drugs, diagnostics, vaccines, and other products to combat antibiotic-resistant bacteria.

WEB ANNOUNCEMENTS

December 08, 2020

The Global Health Technologies Coalition 2020 Innovating for Impact Partnership award recognizes CARB-X for its work to transform breakthrough scientific research into lifesaving drugs, diagnostics, vaccines, and other products to combat antibiotic-resistant bacteria.

VIDEOS

December 08, 2020

CARB-X: 2020 Partnership Award

BARDA and Chembio Diagnostics collaborate on two rapid point-of-care diagnostic tests to both detect antigens for COVID-19 and detect and differentiate Influenza from COVID-19.

WEB ANNOUNCEMENTS

December 03, 2020

BARDA and Chembio Diagnostics collaborate on two rapid point-of-care diagnostic tests to both detect antigens for COVID-19 and detect and differentiate Influenza from COVID-19.

BARDA DRIVe seeking interested applicants for the Early Notification to Act, Control, and Treat (ENACT) program

WEB ANNOUNCEMENTS

December 02, 2020

BARDA DRIVe seeking interested applicants for the Early Notification to Act, Control, and Treat (ENACT) program

News release from HHS.gov: Trump Administration purchases additional doses of Lilly therapeutic to treat patients with mild to moderate COVID-19

WEB ANNOUNCEMENTS

December 02, 2020

News release from HHS.gov: Trump Administration purchases additional doses of Lilly therapeutic to treat patients with mild to moderate COVID-19

BARDA is partnering with Chrysalis BioTherapeutics to continue development of TP508 as a nuclear countermeasure

WEB ANNOUNCEMENTS

November 30, 2020

BARDA is partnering with Chrysalis BioTherapeutics to continue development of TP508 as a nuclear countermeasure

BARDA partners with Siemens Healthineers to expedite development of a high-throughput, automated antigen test for COVID-19

WEB ANNOUNCEMENTS

November 24, 2020

BARDA partners with Siemens Healthineers to expedite development of a high-throughput, automated antigen test for COVID-19

News release from HHS.gov: HHS Provides $25 Million to Siemens Healthineers to Develop and Produce COVID-19 Antigen Diagnostic Tests

WEB ANNOUNCEMENTS

November 23, 2020

News release from HHS.gov: HHS Provides $25 Million to Siemens Healthineers to Develop and Produce COVID-19 Antigen Diagnostic Tests

BLOGS/STORIES

November 19, 2020

BARDA Ventures

BARDA's Reflections on Antibiotic Resistance and the Path Forward

BLOGS/STORIES

November 18, 2020

BARDA's Reflections on Antibiotic Resistance and the Path Forward

BARDA expands partnership with DiaSorin Inc to develop an enhanced IgG assay for determining COVID-19 patient exposure and immune status

WEB ANNOUNCEMENTS

November 16, 2020

BARDA expands partnership with DiaSorin Inc to develop an enhanced IgG assay for determining COVID-19 patient exposure and immune status

BLOGS/STORIES

November 12, 2020

BARDA Ventures: Evolving Federal National Health Security Using Novel Venture Capital-Style Partnership

BARDA seeks nonprofit partner for BARDA Ventures: Catalyzing the 21st Century Cures Act and launching a new way to do business with HHS

WEB ANNOUNCEMENTS

November 10, 2020

BARDA seeks nonprofit partner for BARDA Ventures: Catalyzing the 21st Century Cures Act and launching a new way to do business with HHS

BARDA and JPEO-CBRND help Humanigen evaluate drug to potentially prevent or treat cytokine storm caused by COVID-19

WEB ANNOUNCEMENTS

November 06, 2020

BARDA and JPEO-CBRND help Humanigen evaluate drug to potentially prevent or treat cytokine storm caused by COVID-19

BARDA and Mesa Biotech collaborate on rapid diagnostics to distinguish coronavirus from influenza infections

WEB ANNOUNCEMENTS

November 06, 2020

BARDA and Mesa Biotech collaborate on rapid diagnostics to distinguish coronavirus from influenza infections

Message from the Acting BARDA Director: 2020 BARDA Industry Week Wrap Up

WEB ANNOUNCEMENTS

November 06, 2020

Message from the Acting BARDA Director: 2020 BARDA Industry Week Wrap Up

News release from HHS.gov: HHS and DOD announce $12.7 million contract with InBios International to boost U.S. production of rapid COVID-19 tests

WEB ANNOUNCEMENTS

November 02, 2020

News release from HHS.gov: HHS and DOD announce $12.7 million contract with InBios International to boost U.S. production of rapid COVID-19 tests

News release from HHS.gov: HHS and DOD Announce $119 Million Contract to Hologic to Better Meet the Demand of COVID-19 Testing

WEB ANNOUNCEMENTS

November 02, 2020

News release from HHS.gov: HHS and DOD Announce $119 Million Contract to Hologic to Better Meet the Demand of COVID-19 Testing

HHS, BARDA partner with Hologic to expedite development of a high-throughput, automated multiplex SARS-CoV-2/Flu assay

WEB ANNOUNCEMENTS

October 29, 2020

HHS, BARDA partner with Hologic to expedite development of a high-throughput, automated multiplex SARS-CoV-2/Flu assay

WEB ANNOUNCEMENTS

October 28, 2020

BARDA seeks abstract submissions for medical countermeasure development through the DRIVe ReDIRECT Program

HHS, DOD Collaborate on Plans to Purchase Lilly Investigational Therapeutic to Treat COVID-19

WEB ANNOUNCEMENTS

October 28, 2020

HHS, DOD Collaborate on Plans to Purchase Lilly Investigational Therapeutic to Treat COVID-19

VIDEOS

October 27, 2020

BARDA Industry Day 2020 Presentations

BLOGS/STORIES

October 23, 2020

More than 50 Million BARDA-Supported COVID-19 Diagnostic Tests Shipped to Communities across the US

BARDA engaged Technical Resources International, Inc. (TRI), part of BARDA’s medical countermeasures clinical studies network, to support a large clinical trial as part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative

WEB ANNOUNCEMENTS

October 19, 2020

BARDA engaged Technical Resources International, Inc. (TRI), part of BARDA’s medical countermeasures clinical studies network, to support a large clinical trial as part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative

BARDA Awards Medical Countermeasures Clinical Studies Network

WEB ANNOUNCEMENTS

October 19, 2020

BARDA Awards Medical Countermeasures Clinical Studies Network

VIDEOS

October 17, 2020

Hear directly from the BARDA CBRN director, Dr. Chris Houchens, on his 2021 priorities. BARDA Industry Day 2020

BARDA and Beckman Coulter partner to aid in rapid detection of MIS-C, a pediatric complication of SARS-CoV-2 infection

WEB ANNOUNCEMENTS

October 15, 2020

BARDA and Beckman Coulter partner to aid in rapid detection of MIS-C, a pediatric complication of SARS-CoV-2 infection

News Release from HHS.gov: Trump Administration expands manufacturing capacity with Cytiva for components of COVID-19 vaccines

WEB ANNOUNCEMENTS

October 13, 2020

News Release from HHS.gov: Trump Administration expands manufacturing capacity with Cytiva for components of COVID-19 vaccines

VIDEOS

October 12, 2020

#MakingCountermeasures Series

Trump Administration expands collaboration with AstraZeneca to develop and manufacture an investigational monoclonal antibody to prevent COVID-19

WEB ANNOUNCEMENTS

October 09, 2020

Trump Administration expands collaboration with AstraZeneca to develop and manufacture an investigational monoclonal antibody to prevent COVID-19

BARDA and Current Health partner on remote monitoring to predict likelihood of hospitalization and need for ICU-level support in COVID-19 patients

WEB ANNOUNCEMENTS

October 07, 2020

BARDA and Current Health partner on remote monitoring to predict likelihood of hospitalization and need for ICU-level support in COVID-19 patients

BARDA and DOD JPEO-CBRND Collaborate with Cepheid on Single, Rapid Diagnostic Test to Detect COVID-19, Influenza and RSV

WEB ANNOUNCEMENTS

October 07, 2020

BARDA and DOD JPEO-CBRND Collaborate with Cepheid on Single, Rapid Diagnostic Test to Detect COVID-19, Influenza and RSV

HHS funds development of needle-free vaccine administration technology

WEB ANNOUNCEMENTS

October 06, 2020

HHS funds development of needle-free vaccine administration technology

BARDA partners with Mapp Biopharmaceutical, Inc. to develop next generation therapeutic for Botulinum Neurotoxin

WEB ANNOUNCEMENTS

October 05, 2020

BARDA partners with Mapp Biopharmaceutical, Inc. to develop next generation therapeutic for Botulinum Neurotoxin

Message from the Acting BARDA Director: Thank you for your support in FY2020

WEB ANNOUNCEMENTS

October 05, 2020

Message from the Acting BARDA Director: Thank you for your support in FY2020

Two novel investigational drugs targeting antibiotic-resistant infections move into advanced development with HHS support

WEB ANNOUNCEMENTS

September 30, 2020

Two novel investigational drugs targeting antibiotic-resistant infections move into advanced development with HHS support

BARDA partners with Invirsa to develop a treatment for ocular conditions associated with DNA damage, including sulfur mustard injury

WEB ANNOUNCEMENTS

September 29, 2020

BARDA partners with Invirsa to develop a treatment for ocular conditions associated with DNA damage, including sulfur mustard injury

BARDA awards additional funds to Basilea for next steps in antibiotic development to treat bloodstream infections caused by Staphylococcus aureus bacteria

WEB ANNOUNCEMENTS

September 28, 2020

BARDA awards additional funds to Basilea for next steps in antibiotic development to treat bloodstream infections caused by Staphylococcus aureus bacteria

BARDA and Luminex Corporation partner to expedite development of COVID-19 diagnostic test

WEB ANNOUNCEMENTS

September 24, 2020

BARDA and Luminex Corporation partner to expedite development of COVID-19 diagnostic test

BARDA and Luminex Corporation enter into a public-private partnership to develop an advanced serology test for use during the COVID-19 pandemic

WEB ANNOUNCEMENTS

September 23, 2020

BARDA and Luminex Corporation enter into a public-private partnership to develop an advanced serology test for use during the COVID-19 pandemic

BLOGS/STORIES

September 22, 2020

Clinical Synergies of New Medical Countermeasures in Burn Care

BARDA Partners with University of Pennsylvania Researchers to Develop a Lung-on-a-Chip for Discovery of Treatments for Chlorine Exposure

WEB ANNOUNCEMENTS

September 21, 2020

BARDA Partners with University of Pennsylvania Researchers to Develop a Lung-on-a-Chip for Discovery of Treatments for Chlorine Exposure

BARDA expanded partnership with Ortho Clinical Diagnostics to develop high-throughput, automated COVID-19 antigen and further advancements to antibody tests

WEB ANNOUNCEMENTS

September 18, 2020

BARDA expanded partnership with Ortho Clinical Diagnostics to develop high-throughput, automated COVID-19 antigen and further advancements to antibody tests

BARDA and JPEO-CBRND partner with Ology Bioservices to expand domestic fill-finish capacity for COVID-19 countermeasures under Operation Warp Speed

WEB ANNOUNCEMENTS

September 17, 2020

BARDA and JPEO-CBRND partner with Ology Bioservices to expand domestic fill-finish capacity for COVID-19 countermeasures under Operation Warp Speed

$BARDA and Marinus Partner to Develop New Treatment for Refractory Seizures$

WEB ANNOUNCEMENTS

September 14, 2020

BARDA and Marinus Partner to Develop New Treatment for Refractory Seizures

BARDA and 98point6 partner to accelerate COVID-19 program

WEB ANNOUNCEMENTS

September 11, 2020

BARDA and 98point6 partner to accelerate COVID-19 program

BARDA collaborates with NOWDiagnostics, Inc. to develop a rapid, point-of-care (POC) and over-the-counter (OTC), in vitro diagnostic test to detect antibodies against SARS-CoV-2

WEB ANNOUNCEMENTS

August 31, 2020

BARDA collaborates with NOWDiagnostics, Inc. to develop a rapid, point-of-care (POC) and over-the-counter (OTC), in vitro diagnostic test to detect antibodies against SARS-CoV-2

BARDA establishes four new partnerships to explore innovative vaccine delivery technologies

WEB ANNOUNCEMENTS

August 26, 2020

BARDA establishes four new partnerships to explore innovative vaccine delivery technologies

Trump Administration collaborates with Moderna to produce 100 million doses of COVID-19 investigational vaccine

WEB ANNOUNCEMENTS

August 11, 2020

Trump Administration collaborates with Moderna to produce 100 million doses of COVID-19 investigational vaccine

BARDA and JPEO-CBRND partner with Grand River Aseptic Manufacturing to expand domestic fill-finish capacity for COVID-19 countermeasures under Operation Warp Speed

WEB ANNOUNCEMENTS

August 06, 2020

BARDA and JPEO-CBRND partner with Grand River Aseptic Manufacturing to expand domestic fill-finish capacity for COVID-19 countermeasures under Operation Warp Speed

BARDA supports a second COVID-19 antibody test by DiaSorin, Inc.

WEB ANNOUNCEMENTS

August 06, 2020

BARDA supports a second COVID-19 antibody test by DiaSorin, Inc.

HHS, DOD collaborate with Johnson & Johnson to produce millions of COVID-19 investigational vaccine doses

WEB ANNOUNCEMENTS

August 05, 2020

HHS, DOD collaborate with Johnson & Johnson to produce millions of COVID-19 investigational vaccine doses

Now Accepting Applications for BARDA Industry Day Lightning Talks

WEB ANNOUNCEMENTS

August 03, 2020

Now Accepting Applications for BARDA Industry Day Lightning Talks

EVENTS/MEETINGS

August 01, 2020

BARDA Industry Day 2020

HHS, DOD partner with Sanofi and GSK on commercial-scale manufacturing demonstration project to produce millions of COVID-19 investigational vaccine doses

WEB ANNOUNCEMENTS

July 31, 2020

HHS, DOD partner with Sanofi and GSK on commercial-scale manufacturing demonstration project to produce millions of COVID-19 investigational vaccine doses

BARDA continues to partner with Moderna for the first Phase 3 clinical trial of a COVID-19 vaccine to start in the United States

WEB ANNOUNCEMENTS

July 28, 2020

BARDA continues to partner with Moderna for the first Phase 3 clinical trial of a COVID-19 vaccine to start in the United States

HHS reserves and rapidly expands manufacturing capacity for COVID-19 vaccines at Texas Center for Innovation in Advanced Development and Manufacturing

WEB ANNOUNCEMENTS

July 27, 2020

HHS reserves and rapidly expands manufacturing capacity for COVID-19 vaccines at Texas Center for Innovation in Advanced Development and Manufacturing

U.S. government engages Pfizer to produce millions of doses of COVID-19 vaccine

WEB ANNOUNCEMENTS

July 22, 2020

U.S. government engages Pfizer to produce millions of doses of COVID-19 vaccine

BARDA Industry Day 2020: Lightning Talks Registration Coming Soon

WEB ANNOUNCEMENTS

July 15, 2020

BARDA Industry Day 2020: Lightning Talks Registration Coming Soon

BARDA and JPEO-CBRND form partnership with Smiths Medical to expand domestic manufacturing capacity for safety needles and syringes

WEB ANNOUNCEMENTS

July 15, 2020

BARDA and JPEO-CBRND form partnership with Smiths Medical to expand domestic manufacturing capacity for safety needles and syringes

BARDA and JPEO-CBRND work with Retractable Technologies, Inc. to expand manufacturing of needles and syringes in the US

WEB ANNOUNCEMENTS

July 09, 2020

BARDA and JPEO-CBRND work with Retractable Technologies, Inc. to expand manufacturing of needles and syringes in the US

BARDA and JPEO-CBRND establish partnership with Becton Dickinson to expand domestic manufacturing capacity for needles and syringes

WEB ANNOUNCEMENTS

July 09, 2020

BARDA and JPEO-CBRND establish partnership with Becton Dickinson to expand domestic manufacturing capacity for needles and syringes

BARDA and DoD work with SiO2 Materials Science to increase domestic manufacturing of vials

WEB ANNOUNCEMENTS

July 07, 2020

BARDA and DoD work with SiO2 Materials Science to increase domestic manufacturing of vials

HHS, DOD collaborate with Novavax to produce millions of COVID-19 investigational vaccine doses in commercial-scale manufacturing demonstration project

WEB ANNOUNCEMENTS

July 07, 2020

HHS, DOD collaborate with Novavax to produce millions of COVID-19 investigational vaccine doses in commercial-scale manufacturing demonstration project

HHS, DOD collaborate with Regeneron on large-scale manufacturing demonstration project of COVID-19 investigational therapeutic treatmen

WEB ANNOUNCEMENTS

July 07, 2020

HHS, DOD collaborate with Regeneron on large-scale manufacturing demonstration project of COVID-19 investigational therapeutic treatmen

BARDA partners with Chembio Diagnostics, Inc. to develop a point-of-care in vitro diagnostic test for the detection of SARS-CoV-2 in respiratory specimens

WEB ANNOUNCEMENTS

July 06, 2020

BARDA partners with Chembio Diagnostics, Inc. to develop a point-of-care in vitro diagnostic test for the detection of SARS-CoV-2 in respiratory specimens

BARDA and Sonica Health expand partnership to develop wearable patch as an early monitoring platform for COVID-19 infection

WEB ANNOUNCEMENTS

July 01, 2020

BARDA and Sonica Health expand partnership to develop wearable patch as an early monitoring platform for COVID-19 infection

WEB ANNOUNCEMENTS

July 01, 2020

BARDA Industry Day 2020: Save the Date

BARDA partners with Colorado State University’s Infectious Disease Research Center (IDRC) to further develop the SolaVAXTM platform to address COVID-19

WEB ANNOUNCEMENTS

June 25, 2020

BARDA partners with Colorado State University’s Infectious Disease Research Center (IDRC) to further develop the SolaVAXTM platform to address COVID-19

BARDA partners with MBio Diagnostics to develop an in vitro point-of-care serology test for the detection of human anti-SARS-CoV-2 antibodies from whole blood samples

WEB ANNOUNCEMENTS

June 23, 2020

BARDA partners with MBio Diagnostics to develop an in vitro point-of-care serology test for the detection of human anti-SARS-CoV-2 antibodies from whole blood samples

BLOGS/STORIES

June 22, 2020

Why Sepsis Solutions Can Help COVID-19 Patients

BARDA Teams Up with DoD’s JPEO-CBRN and Corning Incorporated to Expand Production of Corning’s Valor ® Glass Vials

WEB ANNOUNCEMENTS

June 19, 2020

BARDA Teams Up with DoD’s JPEO-CBRN and Corning Incorporated to Expand Production of Corning’s Valor ® Glass Vials

BARDA & Empatica forge new partnership to develop an early monitoring platform to identify COVID-19 infection

WEB ANNOUNCEMENTS

June 19, 2020

BARDA & Empatica forge new partnership to develop an early monitoring platform to identify COVID-19 infection

BARDA supports development of two automated antibody tests for COVID-19 by Ortho Clinical Diagnostics

WEB ANNOUNCEMENTS

June 17, 2020

BARDA supports development of two automated antibody tests for COVID-19 by Ortho Clinical Diagnostics

BARDA and Immunexpress Inc. expand partnership to evaluate a sepsis host-based laboratory diagnostic to triage COVID-19 patients

WEB ANNOUNCEMENTS

June 16, 2020

BARDA and Immunexpress Inc. expand partnership to evaluate a sepsis host-based laboratory diagnostic to triage COVID-19 patients

FDA ends emergency use authorization (EUA) of hydroxychloroquine

WEB ANNOUNCEMENTS

June 15, 2020

FDA ends emergency use authorization (EUA) of hydroxychloroquine

BARDA funds two first-in-human studies for Regeneron’s COVID-19 antibody cocktail

WEB ANNOUNCEMENTS

June 15, 2020

BARDA funds two first-in-human studies for Regeneron’s COVID-19 antibody cocktail

BARDA DRIVe and Sepsis Alliance to provide educational content on COVID-19 and Sepsis

WEB ANNOUNCEMENTS

June 11, 2020

BARDA DRIVe and Sepsis Alliance to provide educational content on COVID-19 and Sepsis

BARDA, Snapdragon Chemistry Inc., demonstrate deployable domestic manufacturing technology for COVID-19 vaccine component

WEB ANNOUNCEMENTS

June 11, 2020

BARDA, Snapdragon Chemistry Inc., demonstrate deployable domestic manufacturing technology for COVID-19 vaccine component

BARDA, Chembio Diagnostics Partnership Results in FDA-Cleared Diagnostic Test for Zika

WEB ANNOUNCEMENTS

June 10, 2020

BARDA, Chembio Diagnostics Partnership Results in FDA-Cleared Diagnostic Test for Zika

Latest BARDA collaboration with OraSure Technologies Inc. aims to develop highly reliable, high-throughput diagnostic test for SARS-CoV-2 antibodies in oral fluids

WEB ANNOUNCEMENTS

June 10, 2020

Latest BARDA collaboration with OraSure Technologies Inc. aims to develop highly reliable, high-throughput diagnostic test for SARS-CoV-2 antibodies in oral fluids

BARDA, DARPA, and AstraZeneca Collaborate to Develop a Novel COVID-19 Therapeutic

WEB ANNOUNCEMENTS

June 09, 2020

BARDA, DARPA, and AstraZeneca Collaborate to Develop a Novel COVID-19 Therapeutic

BARDA engages Moderna to expand domestic manufacturing of the Moderna SARS-CoV-2 vaccine (mRNA-1273) to protect against COVID-19

WEB ANNOUNCEMENTS

June 05, 2020

BARDA engages Moderna to expand domestic manufacturing of the Moderna SARS-CoV-2 vaccine (mRNA-1273) to protect against COVID-19

BARDA partners with Evidation Health to identify COVID-19 infections more quickly in healthcare workers and first responders using self-monitoring and wearable devices

WEB ANNOUNCEMENTS

June 04, 2020

BARDA partners with Evidation Health to identify COVID-19 infections more quickly in healthcare workers and first responders using self-monitoring and wearable devices

BARDA partners with Quidel Corporation to develop one-hour, mobile-integrated multiplex test on Sofia platform to detect SARS-COV-2 plus three additional respiratory viruses

WEB ANNOUNCEMENTS

June 02, 2020

BARDA partners with Quidel Corporation to develop one-hour, mobile-integrated multiplex test on Sofia platform to detect SARS-COV-2 plus three additional respiratory viruses

BARDA announces partnership with Siemens Healthineers to develop automated total antibody test for COVID-19

WEB ANNOUNCEMENTS

June 02, 2020

BARDA announces partnership with Siemens Healthineers to develop automated total antibody test for COVID-19

BARDA and Genentech expand partnership to begin Phase 2 clinical trial to evaluate investigational treatments for COVID-19 patients

WEB ANNOUNCEMENTS

June 01, 2020

BARDA and Genentech expand partnership to begin Phase 2 clinical trial to evaluate investigational treatments for COVID-19 patients

HHS Adds $628 Million to Contract with Emergent BioSolutions to Secure Manufacturing Capacity for Operation Warp Speed

WEB ANNOUNCEMENTS

June 01, 2020

HHS Adds $628 Million to Contract with Emergent BioSolutions to Secure Manufacturing Capacity for Operation Warp Speed

BARDA partners with Merck and IAVI to accelerate development of a vaccine to prevent COVID-19

WEB ANNOUNCEMENTS

May 26, 2020

BARDA partners with Merck and IAVI to accelerate development of a vaccine to prevent COVID-19

Trump Administration’s Operation Warp Speed accelerates AstraZeneca COVID-19 vaccine to be available beginning in October

WEB ANNOUNCEMENTS

May 21, 2020

Trump Administration’s Operation Warp Speed accelerates AstraZeneca COVID-19 vaccine to be available beginning in October

BARDA and VitalConnect partner to monitor nursing home and COVID-19 patients for early indication of patient deterioration

WEB ANNOUNCEMENTS

May 20, 2020

BARDA and VitalConnect partner to monitor nursing home and COVID-19 patients for early indication of patient deterioration

BLOGS/STORIES

May 20, 2020

A Critical Time to be in Public Service: A Perspective from a Pair of Experienced Doctors Caring for COVID-19 Patients

HHS, industry partners expand U.S.-based pharmaceutical manufacturing for COVID-19 response

WEB ANNOUNCEMENTS

May 19, 2020

HHS, industry partners expand U.S.-based pharmaceutical manufacturing for COVID-19 response

BARDA announces expanded partnership with Beckman Coulter to assess digital sepsis prediction solution for COVID-19 patients

WEB ANNOUNCEMENTS

May 15, 2020

BARDA announces expanded partnership with Beckman Coulter to assess digital sepsis prediction solution for COVID-19 patients

BLOGS/STORIES

May 15, 2020

Raising Awareness: Many Roads Lead to Sepsis, Even for COVID-19 Patients

BARDA supports development of AI-based handheld ultrasound to triage trauma or lung injuries and disease diagnosis, including COVID-19

WEB ANNOUNCEMENTS

May 08, 2020

BARDA supports development of AI-based handheld ultrasound to triage trauma or lung injuries and disease diagnosis, including COVID-19

BARDA engages in a collaboration to support Mayo Clinic Expanded Access Program for use of convalescent plasma to hospitalized patients with COVID-19

WEB ANNOUNCEMENTS

May 04, 2020

BARDA engages in a collaboration to support Mayo Clinic Expanded Access Program for use of convalescent plasma to hospitalized patients with COVID-19

BARDA expands partnership with Hologic for development of a second high-throughput molecular assay for SARS-CoV-2

WEB ANNOUNCEMENTS

May 01, 2020

BARDA expands partnership with Hologic for development of a second high-throughput molecular assay for SARS-CoV-2

BARDA expands collaboration with Cerus Corporation to evaluate the INTERCEPT Blood System against SARS-CoV-2

WEB ANNOUNCEMENTS

April 28, 2020

BARDA expands collaboration with Cerus Corporation to evaluate the INTERCEPT Blood System against SARS-CoV-2

BARDA and InBios International, Inc. partner to expedite development for serological tests to identify asymptomatic or recovered cases of COVID-19

WEB ANNOUNCEMENTS

April 27, 2020

BARDA and InBios International, Inc. partner to expedite development for serological tests to identify asymptomatic or recovered cases of COVID-19

BARDA and America’s Blood Centers partner to support and coordinate collection and distribution of convalescent plasma units for COVID-19 patients’ therapeutic use

WEB ANNOUNCEMENTS

April 27, 2020

BARDA and America’s Blood Centers partner to support and coordinate collection and distribution of convalescent plasma units for COVID-19 patients’ therapeutic use

BARDA announces partnership expansion with Cytovale, Inc. for continued development of Cytovale’s rapid diagnostic system for sepsis as part of COVID-19 pandemic response

WEB ANNOUNCEMENTS

April 23, 2020

BARDA announces partnership expansion with Cytovale, Inc. for continued development of Cytovale’s rapid diagnostic system for sepsis as part of COVID-19 pandemic response

BARDA and Tangen Biosciences, Inc. entered into a public-private partnership to develop a rapid diagnostic test for SARS-CoV-2

WEB ANNOUNCEMENTS

April 20, 2020

BARDA and Tangen Biosciences, Inc. entered into a public-private partnership to develop a rapid diagnostic test for SARS-CoV-2

BARDA supports Hememics Biotechnologies, Inc to develop a rapid antigen and antibody diagnostic to identify current or past SARS-CoV-2 infections in 60 seconds

WEB ANNOUNCEMENTS

April 16, 2020

BARDA supports Hememics Biotechnologies, Inc to develop a rapid antigen and antibody diagnostic to identify current or past SARS-CoV-2 infections in 60 seconds

BARDA and American Red Cross collaborate on convalescent plasma for therapeutic use in COVID-19 infected patients

WEB ANNOUNCEMENTS

April 15, 2020

BARDA and American Red Cross collaborate on convalescent plasma for therapeutic use in COVID-19 infected patients

BARDA and Sanofi prepare for studies of COVID-19 vaccine

WEB ANNOUNCEMENTS

April 15, 2020

BARDA and Sanofi prepare for studies of COVID-19 vaccine

BARDA and Vela Diagnostics USA, Inc. entered into a public-private partnership to develop a rapid diagnostic test for the COVID-19 pandemic

WEB ANNOUNCEMENTS

April 14, 2020

BARDA and Vela Diagnostics USA, Inc. entered into a public-private partnership to develop a rapid diagnostic test for the COVID-19 pandemic

HHS facilitates development of immunotherapies for COVID-19 patients

WEB ANNOUNCEMENTS

April 13, 2020

HHS facilitates development of immunotherapies for COVID-19 patients

HHS/BARDA supports DiaSorin, Inc to develop a fully automated serology test to detect novel coronavirus infections

WEB ANNOUNCEMENTS

April 13, 2020

HHS/BARDA supports DiaSorin, Inc to develop a fully automated serology test to detect novel coronavirus infections

HHS supports Nanomix, Inc to develop a rapid mobile diagnostic test to detect presence of current or past COVID-19 infection in patients

WEB ANNOUNCEMENTS

April 08, 2020

HHS supports Nanomix, Inc to develop a rapid mobile diagnostic test to detect presence of current or past COVID-19 infection in patients

HHS, Department of Defense, and Grifols Collaborate to Develop Plasma-based Treatment for COVID-19

WEB ANNOUNCEMENTS

April 07, 2020

HHS, Department of Defense, and Grifols Collaborate to Develop Plasma-based Treatment for COVID-19

BARDA leverages CIADM Partner for Development of Plasma-based Therapeutic Treatment for COVID-19

WEB ANNOUNCEMENTS

April 07, 2020

BARDA leverages CIADM Partner for Development of Plasma-based Therapeutic Treatment for COVID-19

BARDA and Genentech collaborate to accelerate clinical trial of a novel COVID-19 therapeutic treatment

WEB ANNOUNCEMENTS

April 07, 2020

BARDA and Genentech collaborate to accelerate clinical trial of a novel COVID-19 therapeutic treatment

HHS accepts donations of medicine to Strategic National Stockpile as possible treatments for COVID-19 patients

WEB ANNOUNCEMENTS

April 06, 2020

HHS accepts donations of medicine to Strategic National Stockpile as possible treatments for COVID-19 patients

BARDA is partnering with OraSure Technologies Inc. to develop first rapid at-home COVID-19 diagnostic test

WEB ANNOUNCEMENTS

April 06, 2020

BARDA is partnering with OraSure Technologies Inc. to develop first rapid at-home COVID-19 diagnostic test

BARDA, Department of Defense, and SAb Biotherapeutics to Partner to Develop a Novel COVID-19 Therapeutic

WEB ANNOUNCEMENTS

April 01, 2020

BARDA, Department of Defense, and SAb Biotherapeutics to Partner to Develop a Novel COVID-19 Therapeutic

BARDA Collaborates with GenMark Dx on a Rapid Diagnostic Test to Detect COVID-19

WEB ANNOUNCEMENTS

April 01, 2020

BARDA Collaborates with GenMark Dx on a Rapid Diagnostic Test to Detect COVID-19

BARDA Supports Luminex Corporation Development of a Second Diagnostic Test to Detect Novel Coronavirus Infections

WEB ANNOUNCEMENTS

April 01, 2020

BARDA Supports Luminex Corporation Development of a Second Diagnostic Test to Detect Novel Coronavirus Infections

HHS expands partnership with Janssen to develop coronavirus therapeutics

WEB ANNOUNCEMENTS

March 31, 2020

HHS expands partnership with Janssen to develop coronavirus therapeutics

HHS engages Moderna’s mRNA technology to accelerate development of a COVID-19 vaccine

WEB ANNOUNCEMENTS

March 31, 2020

HHS engages Moderna’s mRNA technology to accelerate development of a COVID-19 vaccine

Janssen Research and Development partner with BARDA to accelerate clinical trials and manufacturing of COVID-19 vaccine

WEB ANNOUNCEMENTS

March 31, 2020

Janssen Research and Development partner with BARDA to accelerate clinical trials and manufacturing of COVID-19 vaccine

Cue Health partners with BARDA for the development of a rapid, point-of-care SARS-CoV-2 Test

WEB ANNOUNCEMENTS

March 31, 2020

Cue Health partners with BARDA for the development of a rapid, point-of-care SARS-CoV-2 Test

BARDA and Luminex Corporation Partner to Expedite Development and EUA Clearance for COVID-19 Diagnostic Test

WEB ANNOUNCEMENTS

March 31, 2020

BARDA and Luminex Corporation Partner to Expedite Development and EUA Clearance for COVID-19 Diagnostic Test

HHS, DoD collaborate with Cepheid on rapid diagnostics to detect coronavirus infections

WEB ANNOUNCEMENTS

March 22, 2020

HHS, DoD collaborate with Cepheid on rapid diagnostics to detect coronavirus infections

HHS, DoD collaborate with Mesa Biotech on rapid diagnostics to detect coronavirus infections

WEB ANNOUNCEMENTS

March 20, 2020

HHS, DoD collaborate with Mesa Biotech on rapid diagnostics to detect coronavirus infections

BARDA partners with Qiagen to develop a rapid COVID-19 diagnostic test

WEB ANNOUNCEMENTS

March 20, 2020

BARDA partners with Qiagen to develop a rapid COVID-19 diagnostic test

HHS collaborates with DiaSorin Molecular to develop a COVID-19 diagnostic test

WEB ANNOUNCEMENTS

March 20, 2020

HHS collaborates with DiaSorin Molecular to develop a COVID-19 diagnostic test

HHS funds development of COVID-19 diagnostic tests

WEB ANNOUNCEMENTS

March 13, 2020

HHS funds development of COVID-19 diagnostic tests

HHS Supports Development of First High-Throughput COVID-19 Diagnostic Test; SARS-CoV-2; EZ-BAA

WEB ANNOUNCEMENTS

March 09, 2020

HHS Supports Development of First High-Throughput COVID-19 Diagnostic Test; SARS-CoV-2; EZ-BAA

WEB ANNOUNCEMENTS

March 09, 2020

HHS Supports Development of First High-Throughput COVID-19 Diagnostic Test

BLOGS/STORIES

February 22, 2020

BARDA Leverages Strong Public-Private Partnerships to Spur a Rapid Response to the Novel Coronavirus Outbreak

HHS Engages Sanofi’s Recombinant Technology for 2019 Novel Coronavirus Vaccine

WEB ANNOUNCEMENTS

February 18, 2020

HHS Engages Sanofi’s Recombinant Technology for 2019 Novel Coronavirus Vaccine

HHS, Janssen Collaborate To Develop Coronavirus Therapeutics

WEB ANNOUNCEMENTS

February 18, 2020

HHS, Janssen Collaborate To Develop Coronavirus Therapeutics

BLOGS/STORIES

February 15, 2020

Sepsis is Skyrocketing in the Medicare Population

HHS, Janssen Join Forces On Coronavirus Vaccine

WEB ANNOUNCEMENTS

February 11, 2020

HHS, Janssen Join Forces On Coronavirus Vaccine

HHS Seeks Abstract Submissions for 2019-nCoV Diagnostics Development

WEB ANNOUNCEMENTS

February 05, 2020

HHS Seeks Abstract Submissions for 2019-nCoV Diagnostics Development

HHS, Regeneron Collaborate to Develop 2019-nCoV Treatment

WEB ANNOUNCEMENTS

February 04, 2020

HHS, Regeneron Collaborate to Develop 2019-nCoV Treatment

New Pandemic Influenza Vaccine Uses Next Generation Technology to Strengthen Health Security

WEB ANNOUNCEMENTS

February 03, 2020

New Pandemic Influenza Vaccine Uses Next Generation Technology to Strengthen Health Security

BLOGS/STORIES

February 03, 2020

New Pandemic Influenza Vaccine Uses Next Generation Technology to Strengthen Health Security

Secretary Azar Declares Public Health Emergency for United States for 2019 Novel Coronavirus

WEB ANNOUNCEMENTS

January 31, 2020

Secretary Azar Declares Public Health Emergency for United States for 2019 Novel Coronavirus

WEB ANNOUNCEMENTS

January 30, 2020

BARDA COVID-19 Market Research

2019 Novel Coronavirus Stakeholder Listening Session

WEB ANNOUNCEMENTS

January 29, 2020

2019 Novel Coronavirus Stakeholder Listening Session

BLOGS/STORIES

January 08, 2020

The Skyrocketing Need for Speed: Partnering to Develop Rapid Diagnostic Tests That Protect Patients From Antibiotic Resistant Infections During Disasters and Every Day

BLOGS/STORIES

December 17, 2019

The Health Security Threat in My Backyard: How My Garden Proved That the US Needs More, Rapid, Diagnostics for Antimicrobial Resistant Infections

BLOGS/STORIES

October 11, 2019

The Power of Partnership: BARDA Ushers in 50th FDA-Approved Product for Health Security

A Close Encounter of the Worst Kind: Sepsis

BLOGS/STORIES

September 18, 2019

A Close Encounter of the Worst Kind: Sepsis

BLOGS/STORIES

August 07, 2019

Crossing the Finish Line: Project BioShield is Transforming the Nation's Health Security with Cutting-Edge Innovation, Sound Investments, and Strong Partnerships

EVENTS/MEETINGS

August 05, 2019

BARDA Industry Day 2019

BLOGS/STORIES

August 05, 2019

Novel Partnerships, Payment Shifts, and Emerging US Leadership for Antimicrobial Drugs

BLOGS/STORIES

July 31, 2019

Building a Better Pipeline of Candidate Products for Project BioShield

BLOGS/STORIES

July 24, 2019

Fifteen Years, Fifteen Stockpiled Countermeasures: Leveraging Project BioShield to Build an Unprecedented Array of Drugs, Vaccines, Therpeutics, and More to Enhance Health Security

BLOGS/STORIES

June 06, 2019

BARDA-Supported Zika Virus Test Receives FDA Clearance; Ready for Clinical Laboratory Use

BLOGS/STORIES

May 24, 2019

A Critical Crash Course in Chemical Decontamination

BLOGS/STORIES

May 13, 2019

Project BioShield: Enhancing Preparedness, Ensuring Treatment Options

BLOGS/STORIES

December 13, 2018

Pandemic Influenza Vaccine: An Investmet in Preparedness that Lasts More Than a Decade

BLOGS/STORIES

October 31, 2018

FDA Approval of Anti-Seizure Drug Provides a New Tool for Protecting Americans During a Chemical Attack

BLOGS/STORIES

August 27, 2018

BARDA and Its Partners Bring New Ammunition to the Battle Against Superbugs

EVENTS/MEETINGS

July 22, 2018

BARDA Industry Day 2018

BLOGS/STORIES

July 13, 2018

New Smallpox Antiviral Increases Health Security

BLOGS/STORIES

May 21, 2018

From 1918 to 2018: BARDA's Role in the Evolution of Pandemic Preparedness

BLOGS/STORIES

April 11, 2018

Decontamination Decoded: Disrobing, Dry Wiping Removes 99% of Chemical Decontaminants

BLOGS/STORIES

November 20, 2017

BARDA Supports a Rapid, Deployable, Sensitive Diagnostic Platform to Diagnose Anthrax

BLOGS/STORIES

August 30, 2017

BARDA Adds New Antibiotic to Treat Drug-Resistant Bacterial Infections in Order to Protect the American Public

BLOGS/STORIES

August 02, 2017

New Frontiers and Extreme Environments: BARDA and NASA Join Forces to Better Protect the American Public and Astronauts from Radiation Injury

EVENTS/MEETINGS

July 22, 2017

BARDA Industry Day 2017

BLOGS/STORIES

March 30, 2017

Powering the Next Generation of Antibacterial Innovation to Enhance National Security

BLOGS/STORIES

February 06, 2017

Next-Generation Burn Care Products and Strategies Draw on Innovative Ideas

BLOGS/STORIES

January 09, 2017

BARDA-Supported Zika Vaccine Candidate Enters Clinical Trial

BLOGS/STORIES

October 13, 2016

Better Preparing for Future Ebola Outbreaks Globally

EVENTS/MEETINGS

July 22, 2016

BARDA Industry Day 2016

BLOGS/STORIES

June 07, 2016

Anticipating Threats, Investing in Solutions

BLOGS/STORIES

March 21, 2016

PHEMCE-Supported Drug Achieves FDA Approval

BLOGS/STORIES

March 17, 2016

Would Old Vaccine Work if Needed During a Pandemic?

BLOGS/STORIES

February 19, 2016

BARDA Seeks to Launch a Novel Partnership, a Product Accelerator to Address Antimicrobial Resistance

EVENTS/MEETINGS

January 06, 2016

Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Stakeholders Workshop 2016

BLOGS/STORIES

December 21, 2015

Better Protecting Our Nation Against Future Anthrax Attacks

BLOGS/STORIES

November 25, 2015

Your Thanksgiving Bird Flu the Coop?

BLOGS/STORIES

November 19, 2015

Fighting Antibiotic Resistance: The Long Road to New Solutions

EVENTS/MEETINGS

November 02, 2015

JPM-MCS Industry Day : Proposed Other Transaction Agreement (OTA)

EVENTS/MEETINGS

October 14, 2015

BARDA Industry Day 2015

Innovative Partnerships Support Antibiotic

BLOGS/STORIES

September 23, 2015

Innovative Partnerships Support Antibiotic

EVENTS/MEETINGS

April 03, 2015

MERS-CoV Preparedness Workshop

BLOGS/STORIES

February 24, 2015

BARDA Continues Efforts to Make Ebola Therapeutics Available for Response

BLOGS/STORIES

February 18, 2015

Strong Partnerships are Helping Bring Next Generation Antibiotics to Market

BLOGS/STORIES

December 23, 2014

BARDA-Sponsored Flu Drug Earns FDA Approval

BLOGS/STORIES

November 25, 2014

Protecting Antibiotics by Strengthening the Antibiotic Pipeline

BLOGS/STORIES

November 17, 2014

Developing an Ebola Therapeutic

EVENTS/MEETINGS

October 15, 2014

BARDA Industry Day 2014

BLOGS/STORIES

July 09, 2014

Using Innovative Business Models Enhance Antibiotic Development

BLOGS/STORIES

June 24, 2014

BARDA Broad Spectrum Antimicrobials (BSA) Program

BLOGS/STORIES

June 16, 2014

How is BARDA Positioned to Respond to the Threat?

BLOGS/STORIES

June 10, 2014

What is Antibiotic Resistance and Why is it a Problem?

BLOGS/STORIES

February 13, 2014

Changing the Landscape for Global Pandemic Influenza Vaccine Manufacturing

BLOGS/STORIES

December 06, 2013

Building and Sustaining a Robust Medical Countermeasures Pipeline

BLOGS/STORIES

November 13, 2013

Award Winning Pandemic Influenza Preparedness

EVENTS/MEETINGS

November 12, 2013

BARDA Industry Day 2013

BLOGS/STORIES

September 16, 2013

Planning to Keep the Nation Safe

EVENTS/MEETINGS

September 04, 2013

BARDA Broad Agency Announcement Pre-Proposal Conference

BLOGS/STORIES

December 13, 2012

Can Rapid, Near-Patient Flu Tests Improve Public Health Preparedness and Response?

EVENTS/MEETINGS

December 12, 2012

BARDA Industry Day - Contracting for Countermeasures 2012

EVENTS/MEETINGS

November 15, 2012

BARDA-NHLBI Blood Symposium

EVENTS/MEETINGS

July 12, 2012

The BARDA Multi-Broad Agency Announcement Pre-Proposal Conference 2012

EVENTS/MEETINGS

October 17, 2011

Boston BARDA Industry Day Contracting for Countermeasures

EVENTS/MEETINGS

June 07, 2011

Barda Industry Day Contracting for CounterMeasures

EVENTS/MEETINGS

February 10, 2011

5th Annual PHEMCE Stakeholders Workshop and BARDA Industry Day

EVENTS/MEETINGS

December 02, 2009

HHS PHEMCE Stakeholders Workshop 2009 and BARDA Industry Day

EVENTS/MEETINGS

June 25, 2009

CBRN Medical Countermeasures Workshop

EVENTS/MEETINGS

September 24, 2008

HHS PHEMCE Stakeholders Workshop 2008 and BARDA Industry Day

EVENTS/MEETINGS

August 03, 2007

2007 Biomedical Advanced Research and Development Authority (BARDA) Industry Day

EVENTS/MEETINGS

July 31, 2007

HHS PHEMC Enterprise Stakeholders Workshop

EVENTS/MEETINGS

October 24, 2006

BioShield Stakeholders Workshop

PRODUCTS

BARDA COVID-19 Medicalcountermeasure Products

PRODUCTS

BARDA Chemical, Biological, Radiological & Nuclear (CBRN) Products

PRODUCTS

BARDA DRIVe Products

Announcements & Media

EXPLORE ARTICLES

BARDA RESEARCH

Navigation

Resources

Popular

Social Media

I WANT TO FIND

Announcements & Media

Follow Us

EXPLORE ARTICLES

BARDA RESEARCH